| Product Code: ETC8195356 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Malta continued to be a key destination for large molecule drug substance CDMO import shipments, with the UK, Germany, Italy, Netherlands, and Spain being the top exporting countries. The high concentration levels, as indicated by the Herfindahl-Hirschman Index (HHI), suggest a competitive market landscape. Despite a modest compound annual growth rate (CAGR) of 2.77% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -50.11%, reflecting potential shifts in market dynamics or external factors influencing the industry.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Large Molecule Drug Substance CDMO Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Malta Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Malta Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and large molecule drugs in the pharmaceutical industry |
4.2.2 Growing trend of outsourcing drug substance manufacturing to contract development and manufacturing organizations (CDMOs) |
4.2.3 Advancements in technology and expertise in large molecule drug substance manufacturing in Malta |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards for large molecule drug substance manufacturing |
4.3.2 Intense competition among CDMOs in Malta |
4.3.3 Challenges in scaling up production capacity and maintaining cost efficiency |
5 Malta Large Molecule Drug Substance CDMO Market Trends |
6 Malta Large Molecule Drug Substance CDMO Market, By Types |
6.1 Malta Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Malta Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Malta Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Malta Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Malta Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Malta Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Malta Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Malta Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of repeat business from existing clients |
8.2 Number of new partnerships or collaborations with pharmaceutical companies |
8.3 Rate of successful technology transfers for large molecule drug substance manufacturing |
9 Malta Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Malta Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Malta Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Malta Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Malta Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Malta Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Malta Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here